BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190910T114500
DTEND;TZID=America/New_York:20190910T130000
DTSTAMP:20190821T151231Z
CREATED:20190821T151231Z
LAST-MODIFIED:20190821T151231Z
UID:6297-1568115900-1568120400@scienceinboston.com
SUMMARY:From Bedside to Bench—Streamlined Workflow for Disease-modeling Using Patient-specific iPSC-derived Neurons.
DESCRIPTION:Join us and fellow scientists for lunch and a seminar on streamlining your workflow for disease modeling using patient-specific iPSC-derived neurons. The seminar will be held at STEMCELL Technologies’ office in Cambridge\, MA and feature the Assistant Director of Human Neuron Differentiation Services at Boston Children’s Hospital’s Human Neuron Core\, Dr. Ivy Pin-Fang Chen. Complimentary lunch will be provided. \nSpace is limited. RSVP before Sep 3 to reserve your spot! \n\n\n\n\n\n\nIvy Pin-Fang Chen\, PhD\nAssistant Director\, Human Neuron Differentiation Services\nHuman Neuron Core\, Boston Children’s Hospital\n\n\n\n\n\n\n\nFrom Bedside to Bench—Streamlined Workflow for Disease-modeling Using Patient-specific iPSC-derived Neurons.Tuesday\, Sep 10\, 2019 | 11:45 a.m. – 1:00 p.m. \nLocationSTEMCELL Technologies Inc. Cambridge Office\n222 Third Street\, Suite 2323\, Cambridge\, MA
URL:https://scienceinboston.com/event/from-bedside-to-bench-streamlined-workflow-for-disease-modeling-using-patient-specific-ipsc-derived-neurons/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190910T114500
DTEND;TZID=America/New_York:20190910T130000
DTSTAMP:20190821T151231Z
CREATED:20190821T151231Z
LAST-MODIFIED:20190821T151231Z
UID:27324-1568115900-1568120400@scienceinboston.com
SUMMARY:From Bedside to Bench—Streamlined Workflow for Disease-modeling Using Patient-specific iPSC-derived Neurons.
DESCRIPTION:Join us and fellow scientists for lunch and a seminar on streamlining your workflow for disease modeling using patient-specific iPSC-derived neurons. The seminar will be held at STEMCELL Technologies’ office in Cambridge\, MA and feature the Assistant Director of Human Neuron Differentiation Services at Boston Children’s Hospital’s Human Neuron Core\, Dr. Ivy Pin-Fang Chen. Complimentary lunch will be provided. \nSpace is limited. RSVP before Sep 3 to reserve your spot! \n\n\n\n\n\n\nIvy Pin-Fang Chen\, PhD\nAssistant Director\, Human Neuron Differentiation Services\nHuman Neuron Core\, Boston Children’s Hospital\n\n\n\n\n\n\n\nFrom Bedside to Bench—Streamlined Workflow for Disease-modeling Using Patient-specific iPSC-derived Neurons.Tuesday\, Sep 10\, 2019 | 11:45 a.m. – 1:00 p.m. \nLocationSTEMCELL Technologies Inc. Cambridge Office\n222 Third Street\, Suite 2323\, Cambridge\, MA
URL:https://scienceinboston.com/event/from-bedside-to-bench-streamlined-workflow-for-disease-modeling-using-patient-specific-ipsc-derived-neurons-2/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T170000
DTEND;TZID=America/New_York:20190909T190000
DTSTAMP:20190909T143453Z
CREATED:20190909T143453Z
LAST-MODIFIED:20190909T143453Z
UID:27327-1568048400-1568055600@scienceinboston.com
SUMMARY:CyTOF Analysis Workshop Series
DESCRIPTION:Invited speakers from Dana-Farber Cancer Institute and Bluebird Bio will talk about panel validation and addressing batch effect.\n\n\n\n\n\n\nAbout this Event\n\n\nSpeaker: Emily Thrash\, PhD\, Scientist II\, Dana-Farber Cancer Institute\nBio: Experienced Cancer Immunologist with a proven history of developing clinical trial correlative studies. Highly skilled in Flow Cytometry and CyTOF\, especially with primary patient samples. Patient-oriented\, results-driven research professional with a Doctorate in Biomedical Sciences\, Immunology from The Ohio State University College of Medicine. \nAbstract: CyTOF is revolutionizing correlative clinical trial studies allowing for deeper immune-phenotyping compared to traditional flow cytometry. Leveraging CyTOF technology\, our group has previously identified biomarkers of response to anti-PD-1 therapy in melanoma patients. Building upon those studies\, we have developed two CyTOF panels 1) Adaptive (CPB-A) and 2) Innate (CPB-I) that identify immune cell subsets and test biomarkers for response and resistance in patients receiving anti-PD-1 therapy. Here we present the validation of these panels\, as well as our method pipeline for CyTOF panel development. \nSpeaker: Brandon Nguyen\, Sr. Associate Scientist I\, Bluebird Bio\nAbstract: Mass Cytometry presents a unique opportunity to look at 40 antigens at once on a single cell basis\, this is particularly useful when trying to phenotypically characterize a cellular drug product. Currently at bluebird bio there are three clinical phase cellular drug products that leverage autologous CD34+ hematopoietic stem cells edited with lentiviral vector. Because hematopoiesis is a very fluid landscape\, we have developed a classification method to divide the CD34+ drug product into lineage specific progenitors and precursors with the help of high dimensional clustering. This characterization data set can then be used for correlative studies within each clinical trial and across multiple clinical trials. However\, in order to ensure data integrity for meaningful comparative studies a reference must be used to track staining consistency of each antibody. This was found to be necessary as batch effects played an important role into the potential skewing of high dimensional analysis. Overall\, longitudinal studies are a challenge due to batch specific staining variation\, however the variation can be minimized by tracking a reference cell bank and strategic optimization.
URL:https://scienceinboston.com/event/cytof-analysis-workshop-series-2/
LOCATION:Bluebird Bio\, 60 Binney Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T170000
DTEND;TZID=America/New_York:20190909T190000
DTSTAMP:20190909T143544Z
CREATED:20190909T143453Z
LAST-MODIFIED:20190909T143544Z
UID:6424-1568048400-1568055600@scienceinboston.com
SUMMARY:CyTOF Analysis Workshop Series
DESCRIPTION:Invited speakers from Dana-Farber Cancer Institute and Bluebird Bio will talk about panel validation and addressing batch effect.\n\n\n\n\n\n\nAbout this Event\n\n\nSpeaker: Emily Thrash\, PhD\, Scientist II\, Dana-Farber Cancer Institute\nBio: Experienced Cancer Immunologist with a proven history of developing clinical trial correlative studies. Highly skilled in Flow Cytometry and CyTOF\, especially with primary patient samples. Patient-oriented\, results-driven research professional with a Doctorate in Biomedical Sciences\, Immunology from The Ohio State University College of Medicine. \nAbstract: CyTOF is revolutionizing correlative clinical trial studies allowing for deeper immune-phenotyping compared to traditional flow cytometry. Leveraging CyTOF technology\, our group has previously identified biomarkers of response to anti-PD-1 therapy in melanoma patients. Building upon those studies\, we have developed two CyTOF panels 1) Adaptive (CPB-A) and 2) Innate (CPB-I) that identify immune cell subsets and test biomarkers for response and resistance in patients receiving anti-PD-1 therapy. Here we present the validation of these panels\, as well as our method pipeline for CyTOF panel development. \nSpeaker: Brandon Nguyen\, Sr. Associate Scientist I\, Bluebird Bio\nAbstract: Mass Cytometry presents a unique opportunity to look at 40 antigens at once on a single cell basis\, this is particularly useful when trying to phenotypically characterize a cellular drug product. Currently at bluebird bio there are three clinical phase cellular drug products that leverage autologous CD34+ hematopoietic stem cells edited with lentiviral vector. Because hematopoiesis is a very fluid landscape\, we have developed a classification method to divide the CD34+ drug product into lineage specific progenitors and precursors with the help of high dimensional clustering. This characterization data set can then be used for correlative studies within each clinical trial and across multiple clinical trials. However\, in order to ensure data integrity for meaningful comparative studies a reference must be used to track staining consistency of each antibody. This was found to be necessary as batch effects played an important role into the potential skewing of high dimensional analysis. Overall\, longitudinal studies are a challenge due to batch specific staining variation\, however the variation can be minimized by tracking a reference cell bank and strategic optimization.
URL:https://scienceinboston.com/event/cytof-analysis-workshop-series/
LOCATION:Bluebird Bio\, 60 Binney Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T080000
DTEND;TZID=America/New_York:20190912T200000
DTSTAMP:20190816T142215Z
CREATED:20190816T142215Z
LAST-MODIFIED:20190816T142215Z
UID:6203-1568016000-1568318400@scienceinboston.com
SUMMARY:Biotech Week Boston
DESCRIPTION:Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas\, science\, technology and partnerships to make a positive impact on patient health. \nYou’ll find thought-leaders and potential partners from discovery\, financing\, manufacturing\, clinical trials\, who can help drive you closer to success. It’s an unparalleled opportunity to meet and do business with those who are shaping our industry’s future\, from researchers and investors\, to CEOs and founders. \nAdd a dazzling awards party\, and an evening of rock and roll\, Biotech Week Boston is also the convergence of business and fun.
URL:https://scienceinboston.com/event/biotech-week-boston/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T080000
DTEND;TZID=America/New_York:20190912T200000
DTSTAMP:20190816T142215Z
CREATED:20190816T142215Z
LAST-MODIFIED:20190816T142215Z
UID:27314-1568016000-1568318400@scienceinboston.com
SUMMARY:Biotech Week Boston
DESCRIPTION:Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas\, science\, technology and partnerships to make a positive impact on patient health. \nYou’ll find thought-leaders and potential partners from discovery\, financing\, manufacturing\, clinical trials\, who can help drive you closer to success. It’s an unparalleled opportunity to meet and do business with those who are shaping our industry’s future\, from researchers and investors\, to CEOs and founders. \nAdd a dazzling awards party\, and an evening of rock and roll\, Biotech Week Boston is also the convergence of business and fun.
URL:https://scienceinboston.com/event/biotech-week-boston-2/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T080000
DTEND;TZID=America/New_York:20190912T170000
DTSTAMP:20190815T152715Z
CREATED:20190815T152715Z
LAST-MODIFIED:20190815T152715Z
UID:27311-1568016000-1568307600@scienceinboston.com
SUMMARY:Ergonomics and Human Factors: Strategic Solutions for Workplace Safety and Health
DESCRIPTION:Overview\n\nWork-related musculoskeletal disorders (MSDs) are a leading cause of employee injury and illness across industries and occupations. Fortunately\, work-related MSDs and their associated costs can be prevented through the effective application of ergonomic principles. \nThis applied program brings together professionals from across industries and sectors to prevent work-related musculoskeletal disorders and improve workplace health and safety through ergonomics. Ergonomics and Human Factors explores both the technical skills required to perform job assessments and the organizational factors which contribute to successful ergonomics programs. \nParticipants will complete this program ready to control health and performance problems through ergonomic interventions\, optimize their organization’s ergonomics program\, and improve employee health and safety. \nImprove Employee Health and Safety \nWith a focus on improving worker health and safety\, this program offers practical advice for implementing and optimizing workplace ergonomics programs. In addition\, the technical skills required for occupational ergonomic interventions are explored through lectures\, group work\, and in-depth discussions. This course is unique in considering both the public health and industry perspectives. \nNew Office Ergonomics Sessions \nPoorly designed work stations\, bad work habits\, and prolonged sitting can all have serious adverse health effects. With much of the American workforce performing sedentary work at a desk all day\, office ergonomics has taken on new levels of importance. This course now includes an expanded focus on office ergonomics to address these challenges. New sessions include: \n\nSit Stand Desks and the Necessary Training\nConsiderations for Standing Work\nPhysiology of Sitting\, Standing\, and Walking-Integration of Treadmills to Improve Workstations\nReview of the Evidence for Workstations\nSystem’s Approaches to Combating the Sedentary Workplace\n\nCourse Website
URL:https://scienceinboston.com/event/ergonomics-and-human-factors-strategic-solutions-for-workplace-safety-and-health-2/
LOCATION:Harvard Longwood Campus\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T080000
DTEND;TZID=America/New_York:20190912T170000
DTSTAMP:20190815T152747Z
CREATED:20190815T152715Z
LAST-MODIFIED:20190815T152747Z
UID:6193-1568016000-1568307600@scienceinboston.com
SUMMARY:Ergonomics and Human Factors: Strategic Solutions for Workplace Safety and Health
DESCRIPTION:Overview\n\nWork-related musculoskeletal disorders (MSDs) are a leading cause of employee injury and illness across industries and occupations. Fortunately\, work-related MSDs and their associated costs can be prevented through the effective application of ergonomic principles. \nThis applied program brings together professionals from across industries and sectors to prevent work-related musculoskeletal disorders and improve workplace health and safety through ergonomics. Ergonomics and Human Factors explores both the technical skills required to perform job assessments and the organizational factors which contribute to successful ergonomics programs. \nParticipants will complete this program ready to control health and performance problems through ergonomic interventions\, optimize their organization’s ergonomics program\, and improve employee health and safety. \nImprove Employee Health and Safety \nWith a focus on improving worker health and safety\, this program offers practical advice for implementing and optimizing workplace ergonomics programs. In addition\, the technical skills required for occupational ergonomic interventions are explored through lectures\, group work\, and in-depth discussions. This course is unique in considering both the public health and industry perspectives. \nNew Office Ergonomics Sessions \nPoorly designed work stations\, bad work habits\, and prolonged sitting can all have serious adverse health effects. With much of the American workforce performing sedentary work at a desk all day\, office ergonomics has taken on new levels of importance. This course now includes an expanded focus on office ergonomics to address these challenges. New sessions include: \n\nSit Stand Desks and the Necessary Training\nConsiderations for Standing Work\nPhysiology of Sitting\, Standing\, and Walking-Integration of Treadmills to Improve Workstations\nReview of the Evidence for Workstations\nSystem’s Approaches to Combating the Sedentary Workplace\n\nCourse Website
URL:https://scienceinboston.com/event/ergonomics-and-human-factors-strategic-solutions-for-workplace-safety-and-health/
LOCATION:Harvard Longwood Campus\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T070000
DTEND;TZID=America/New_York:20190912T180000
DTSTAMP:20190815T153644Z
CREATED:20190815T153644Z
LAST-MODIFIED:20190815T153644Z
UID:27313-1568012400-1568311200@scienceinboston.com
SUMMARY:AI Applications for Drug Discovery and Development
DESCRIPTION:Connect with key stakeholders in pharma and biotech to transform scientific research based on better decision-making\, optimized innovation\, improved efficiency of clinical trials\, and new tool creation for physicians\, consumers\, insurers\, and regulators at this year’s AI conference. The program consists of two full days of case studies that will give you the opportunity to learn how to improve R&D productivity\, expedite timelines & identify better drug candidates from target identification right through to post market. The 3rd day\, September 12\, is a dedicated partnering day offering you the opportunity to meet with industry\, academia\, consortia\, associations and tech providers to discuss the hottest trends and innovation in pharma and healthcare to date. \nMassBio member companies can save 10% off the current rate when you register online with VIP code MASSBIO (new registrations only). For full program details and to register\, visit our website.
URL:https://scienceinboston.com/event/ai-applications-for-drug-discovery-and-development-2/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190909T070000
DTEND;TZID=America/New_York:20190912T180000
DTSTAMP:20190815T154121Z
CREATED:20190815T153644Z
LAST-MODIFIED:20190815T154121Z
UID:6196-1568012400-1568311200@scienceinboston.com
SUMMARY:AI Applications for Drug Discovery and Development
DESCRIPTION:Connect with key stakeholders in pharma and biotech to transform scientific research based on better decision-making\, optimized innovation\, improved efficiency of clinical trials\, and new tool creation for physicians\, consumers\, insurers\, and regulators at this year’s AI conference. The program consists of two full days of case studies that will give you the opportunity to learn how to improve R&D productivity\, expedite timelines & identify better drug candidates from target identification right through to post market. The 3rd day\, September 12\, is a dedicated partnering day offering you the opportunity to meet with industry\, academia\, consortia\, associations and tech providers to discuss the hottest trends and innovation in pharma and healthcare to date. \nMassBio member companies can save 10% off the current rate when you register online with VIP code MASSBIO (new registrations only). For full program details and to register\, visit our website.
URL:https://scienceinboston.com/event/ai-applications-for-drug-discovery-and-development/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T113000
DTEND;TZID=America/New_York:20190906T143000
DTSTAMP:20190815T152807Z
CREATED:20190815T151253Z
LAST-MODIFIED:20190815T152807Z
UID:6192-1567769400-1567780200@scienceinboston.com
SUMMARY:Poretta & Orr Lunch & Learn: Maximize Convention Marketing Results - Successful Strategies for Biotechs - Pre-Launch Through Maturity
DESCRIPTION:Sometimes you just don’t know what you don’t know. If you work for a bio start-up or a company that is launching a new drug or device be sure you start thinking of your marketing end game right out of the gate! Knowing where you want to end up is vital to creating a successful strategy from the start. So mark your calendars now! Join MassBio member Poretta & Orr for an informative and interactive Lunch & Learn as we discuss the strategy behind a successful framework for convention planning\, including identification of essential partners and their roles. \n\nRob Metz\, Senior Vice President\, Global Business Operations & Chief Compliance Officer at Horizon Therapeutics is showcased in video clips and interviews that highlight Horizon Therapeutics strategic use of conventions through several phases of company growth and product life cycle.\nA review of best practices relating to conventions\, pre-launch and launch phases is reviewed.\nBest practices pertaining to planning and program evaluation is also a critical component of a successful convention marketing program and discussed.\nAgency collaboration processes and success stories are shared.\n\nRemember\, having a strategy from the beginning is vital to successful\, creative and memorable convention and exhibit marketing. Come ask your questions\, enjoy a delicious lunch and let’s get acquainted!
URL:https://scienceinboston.com/event/poretta-orr-lunch-learn-maximize-convention-marketing-results-successful-strategies-for-biotechs-pre-launch-through-maturity/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T113000
DTEND;TZID=America/New_York:20190906T143000
DTSTAMP:20190815T151253Z
CREATED:20190815T151253Z
LAST-MODIFIED:20190815T151253Z
UID:27310-1567769400-1567780200@scienceinboston.com
SUMMARY:Poretta & Orr Lunch & Learn: Maximize Convention Marketing Results - Successful Strategies for Biotechs - Pre-Launch Through Maturity
DESCRIPTION:Sometimes you just don’t know what you don’t know. If you work for a bio start-up or a company that is launching a new drug or device be sure you start thinking of your marketing end game right out of the gate! Knowing where you want to end up is vital to creating a successful strategy from the start. So mark your calendars now! Join MassBio member Poretta & Orr for an informative and interactive Lunch & Learn as we discuss the strategy behind a successful framework for convention planning\, including identification of essential partners and their roles. \n\nRob Metz\, Senior Vice President\, Global Business Operations & Chief Compliance Officer at Horizon Therapeutics is showcased in video clips and interviews that highlight Horizon Therapeutics strategic use of conventions through several phases of company growth and product life cycle.\nA review of best practices relating to conventions\, pre-launch and launch phases is reviewed.\nBest practices pertaining to planning and program evaluation is also a critical component of a successful convention marketing program and discussed.\nAgency collaboration processes and success stories are shared.\n\nRemember\, having a strategy from the beginning is vital to successful\, creative and memorable convention and exhibit marketing. Come ask your questions\, enjoy a delicious lunch and let’s get acquainted!
URL:https://scienceinboston.com/event/poretta-orr-lunch-learn-maximize-convention-marketing-results-successful-strategies-for-biotechs-pre-launch-through-maturity-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T083000
DTEND;TZID=America/New_York:20190906T180000
DTSTAMP:20190816T142747Z
CREATED:20190816T142747Z
LAST-MODIFIED:20190816T142747Z
UID:6209-1567758600-1567792800@scienceinboston.com
SUMMARY:2nd Annual Dana-Farber Chemical Biology Symposium
DESCRIPTION:We are approaching our capacity for registered attendees at this time! Please add your name to the wait list through EventBrite and we will let you know if space opens up!\n\nWe are delighted to welcome you to the 2nd Annual Dana-Farber Cancer Institute (DFCI) Chemical Biology Symposium! \nThis symposium aims to bring together speakers representing a diverse range of chemical biology research interests\, and highlight important insights\, developments\, and contributions to this unique field. We are excited to include an afternoon career panel discussion in addition to scientific talks. This day-long event is free to attend and open to the public. \nEarly evening poster session and reception to follow talks and afternoon career panel. \nRegistered attendees are also invited to submit poster abstracts here. \nAbstract deadline: August 19\, 2019 \nEvent Agenda\n8:00 – 8:30 AM Arrival and Registration (Coffee will be provided) \n8:30 – 8:45 AM Welcome Remarks \n8:45 – 9:30 AM Keynote Address\nMarion Dorsch \, Ph.D.\, Chief Scientific Officer\, Blueprint Medicines\n“Unlocking the full potential of kinase medicines: highly selective therapies for genomically defined diseases”\n9:30 – 10:00 AM Katya Marjon\, Agios “Targeting MAT2A in MTAP-deleted Cancers.” \n10:00 – 10:30 AM Sloan Devlin\, Harvard Medical School “Bacterial modifications of host metabolites alter host physiology” \n10:30 – 11:00 AM\, Coffee Break\, Jimmy Fund Auditorium Lobby \n11:00 – 11:30 AM Nathalie Agar\, Brigham And Women’s Hospital and Harvard Medical School \n11:30 AM – 12:00 PM Jeremy Jenkins\, Novartis Institute for BioMedical Research (NIBR)\, “Technology advances for characterizing compound MOA” \n12:00 – 1:00 PM Lunch on your own \n1:00 – 1:30 PM Angela Koehler\, Koch Institute at MIT\, “Attenuating Oncogenic Transcription with Small Molecules” \n1:30 – 2:00 PM Eric Fischer\, Dana-Farber Cancer Institute and Harvard Medical School “Principles of small molecule mediated ubiquitin ligase targeting” \n2:00 – 3:00 PM Career Panel Discussion: Christopher Browne (AstraZeneca)\, Janet Ralbovsky (Dana-Farber)\, Mishtu Dey (Cell Press)\, and Dora Carrico-Moniz (Wellesley College) \n3:00 – 3:15 PM Coffee Break\, Jimmy Fund Auditorium Lobby \n3:15 – 4:00 PM Keynote Address\nGarry Nolan\, Ph.D.\, Stanford University School of Medicine\n“Pathology from the molecular scale on up”\n4:00 – 4:05 PM Closing Remarks \n4:05 – 6:00 PM Poster Reception with Light Refreshments\, Yawkey Conference Center \n(submit your posters here) \nTo learn more about this event\, email the DFCI Chemical Biology Program at chemical_biology@dfci.harvard.edu\, or follow us on Twitter at @DFCI_ChemBio #DFCIChemBio2019 \nTo learn more about Chemical Biology @DFCI visit our website. \nDownload our event flyer here and spread the word! \nSee you there!
URL:https://scienceinboston.com/event/2nd-annual-dana-farber-chemical-biology-symposium/
LOCATION:Jimmy Fund Auditorium\, 35 Binney St\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190906T083000
DTEND;TZID=America/New_York:20190906T180000
DTSTAMP:20190816T142747Z
CREATED:20190816T142747Z
LAST-MODIFIED:20190816T142747Z
UID:27316-1567758600-1567792800@scienceinboston.com
SUMMARY:2nd Annual Dana-Farber Chemical Biology Symposium
DESCRIPTION:We are approaching our capacity for registered attendees at this time! Please add your name to the wait list through EventBrite and we will let you know if space opens up!\n\nWe are delighted to welcome you to the 2nd Annual Dana-Farber Cancer Institute (DFCI) Chemical Biology Symposium! \nThis symposium aims to bring together speakers representing a diverse range of chemical biology research interests\, and highlight important insights\, developments\, and contributions to this unique field. We are excited to include an afternoon career panel discussion in addition to scientific talks. This day-long event is free to attend and open to the public. \nEarly evening poster session and reception to follow talks and afternoon career panel. \nRegistered attendees are also invited to submit poster abstracts here. \nAbstract deadline: August 19\, 2019 \nEvent Agenda\n8:00 – 8:30 AM Arrival and Registration (Coffee will be provided) \n8:30 – 8:45 AM Welcome Remarks \n8:45 – 9:30 AM Keynote Address\nMarion Dorsch \, Ph.D.\, Chief Scientific Officer\, Blueprint Medicines\n“Unlocking the full potential of kinase medicines: highly selective therapies for genomically defined diseases”\n9:30 – 10:00 AM Katya Marjon\, Agios “Targeting MAT2A in MTAP-deleted Cancers.” \n10:00 – 10:30 AM Sloan Devlin\, Harvard Medical School “Bacterial modifications of host metabolites alter host physiology” \n10:30 – 11:00 AM\, Coffee Break\, Jimmy Fund Auditorium Lobby \n11:00 – 11:30 AM Nathalie Agar\, Brigham And Women’s Hospital and Harvard Medical School \n11:30 AM – 12:00 PM Jeremy Jenkins\, Novartis Institute for BioMedical Research (NIBR)\, “Technology advances for characterizing compound MOA” \n12:00 – 1:00 PM Lunch on your own \n1:00 – 1:30 PM Angela Koehler\, Koch Institute at MIT\, “Attenuating Oncogenic Transcription with Small Molecules” \n1:30 – 2:00 PM Eric Fischer\, Dana-Farber Cancer Institute and Harvard Medical School “Principles of small molecule mediated ubiquitin ligase targeting” \n2:00 – 3:00 PM Career Panel Discussion: Christopher Browne (AstraZeneca)\, Janet Ralbovsky (Dana-Farber)\, Mishtu Dey (Cell Press)\, and Dora Carrico-Moniz (Wellesley College) \n3:00 – 3:15 PM Coffee Break\, Jimmy Fund Auditorium Lobby \n3:15 – 4:00 PM Keynote Address\nGarry Nolan\, Ph.D.\, Stanford University School of Medicine\n“Pathology from the molecular scale on up”\n4:00 – 4:05 PM Closing Remarks \n4:05 – 6:00 PM Poster Reception with Light Refreshments\, Yawkey Conference Center \n(submit your posters here) \nTo learn more about this event\, email the DFCI Chemical Biology Program at chemical_biology@dfci.harvard.edu\, or follow us on Twitter at @DFCI_ChemBio #DFCIChemBio2019 \nTo learn more about Chemical Biology @DFCI visit our website. \nDownload our event flyer here and spread the word! \nSee you there!
URL:https://scienceinboston.com/event/2nd-annual-dana-farber-chemical-biology-symposium-2/
LOCATION:Jimmy Fund Auditorium\, 35 Binney St\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190905T170000
DTEND;TZID=America/New_York:20190905T190000
DTSTAMP:20190821T150343Z
CREATED:20190821T150343Z
LAST-MODIFIED:20190821T150343Z
UID:6295-1567702800-1567710000@scienceinboston.com
SUMMARY:STEMCELL Career Open House
DESCRIPTION:After a busy day in the lab\, join us for wine and cheese at the annual STEMCELL Career Open House in Kendall Square. \nSpace is limited. Please RSVP before September 4\, 2019 to reserve your spot! \n\n\n\n\nTimeThursday\, September 5\, 2019\, 5:00 pm – 7:00 pm \nLocationSTEMCELL Technologies Inc. Cambridge Office\n2323 – 222 Third Street\, Cambridge\, MA
URL:https://scienceinboston.com/event/stemcell-career-open-house/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190905T170000
DTEND;TZID=America/New_York:20190905T190000
DTSTAMP:20190821T150343Z
CREATED:20190821T150343Z
LAST-MODIFIED:20190821T150343Z
UID:27323-1567702800-1567710000@scienceinboston.com
SUMMARY:STEMCELL Career Open House
DESCRIPTION:After a busy day in the lab\, join us for wine and cheese at the annual STEMCELL Career Open House in Kendall Square. \nSpace is limited. Please RSVP before September 4\, 2019 to reserve your spot! \n\n\n\n\nTimeThursday\, September 5\, 2019\, 5:00 pm – 7:00 pm \nLocationSTEMCELL Technologies Inc. Cambridge Office\n2323 – 222 Third Street\, Cambridge\, MA
URL:https://scienceinboston.com/event/stemcell-career-open-house-2/
LOCATION:STEMCELL Tech\, Suite 2323-222 Third Street\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190903T100000
DTEND;TZID=America/New_York:20190903T180000
DTSTAMP:20190815T152831Z
CREATED:20190815T151042Z
LAST-MODIFIED:20190815T152831Z
UID:6189-1567504800-1567533600@scienceinboston.com
SUMMARY:Bridging the Gap Symposium
DESCRIPTION:The GSAS Harvard Biotechnology Club 20th anniversary symposium will celebrate 20 years of student-driven connections between academia and industry. This meeting will highlight seminal achievements in biotech innovation and commercialization that have occurred since the inception of the club in 1999\, especially those which have made a measurable impact on patients’ lives. A theme of fostered collaboration between industry and academia will be emphasized\, with panels covering the work of entrepreneurial academic investigators and the bond of information transfer between academia and industry. Keynote speakers will provide outlooks on the unique roles of academia and industry in the ecosystem of biotechnology\, and will feature Dean George Daley of Harvard Medical School\, RA Capital Founder and Managing Director Peter Kolchinsky\, and Vertex EVP & CSO David Altshuler. The GSAS Harvard Biotechnology Club is excited to host this meeting as one of its premier initiatives for students seeking futures in biotechnology. \nWhether you’re a prospective or current student\, recent graduate or postdoc\, industry professional or retiree\, we invite you to attend our symposium that will celebrate our 20th year as an organization.
URL:https://scienceinboston.com/event/bridging-the-gap-symposium/
LOCATION:GSAS Harvard Biotech Club\, 423 Brookline Ave.\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190903T100000
DTEND;TZID=America/New_York:20190903T180000
DTSTAMP:20190815T151042Z
CREATED:20190815T151042Z
LAST-MODIFIED:20190815T151042Z
UID:27309-1567504800-1567533600@scienceinboston.com
SUMMARY:Bridging the Gap Symposium
DESCRIPTION:The GSAS Harvard Biotechnology Club 20th anniversary symposium will celebrate 20 years of student-driven connections between academia and industry. This meeting will highlight seminal achievements in biotech innovation and commercialization that have occurred since the inception of the club in 1999\, especially those which have made a measurable impact on patients’ lives. A theme of fostered collaboration between industry and academia will be emphasized\, with panels covering the work of entrepreneurial academic investigators and the bond of information transfer between academia and industry. Keynote speakers will provide outlooks on the unique roles of academia and industry in the ecosystem of biotechnology\, and will feature Dean George Daley of Harvard Medical School\, RA Capital Founder and Managing Director Peter Kolchinsky\, and Vertex EVP & CSO David Altshuler. The GSAS Harvard Biotechnology Club is excited to host this meeting as one of its premier initiatives for students seeking futures in biotechnology. \nWhether you’re a prospective or current student\, recent graduate or postdoc\, industry professional or retiree\, we invite you to attend our symposium that will celebrate our 20th year as an organization.
URL:https://scienceinboston.com/event/bridging-the-gap-symposium-2/
LOCATION:GSAS Harvard Biotech Club\, 423 Brookline Ave.\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190822T133000
DTEND;TZID=America/New_York:20190822T153000
DTSTAMP:20190723T204745Z
CREATED:20190723T204745Z
LAST-MODIFIED:20190723T204745Z
UID:27305-1566480600-1566487800@scienceinboston.com
SUMMARY:MassBio Backyard Bash With World Series Trophies
DESCRIPTION:In the 2018 World Series\, the Boston Red Sox cruised to victory against the Los Angeles Dodgers. \nOn August 22nd\, that very trophy will be coming to MassBio for our first Backyard Bash. Join us in the Technology Square courtyard for sausages\, hot dogs\, a firetruck turned pizza oven\, and a photo opp with the World Series trophies. MassBio members only. Registration and a printed ticket is required for entry.
URL:https://scienceinboston.com/event/massbio-backyard-bash-with-world-series-trophies-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190822T133000
DTEND;TZID=America/New_York:20190822T153000
DTSTAMP:20190723T204745Z
CREATED:20190723T204745Z
LAST-MODIFIED:20190723T204745Z
UID:6000-1566480600-1566487800@scienceinboston.com
SUMMARY:MassBio Backyard Bash With World Series Trophies
DESCRIPTION:In the 2018 World Series\, the Boston Red Sox cruised to victory against the Los Angeles Dodgers. \nOn August 22nd\, that very trophy will be coming to MassBio for our first Backyard Bash. Join us in the Technology Square courtyard for sausages\, hot dogs\, a firetruck turned pizza oven\, and a photo opp with the World Series trophies. MassBio members only. Registration and a printed ticket is required for entry.
URL:https://scienceinboston.com/event/massbio-backyard-bash-with-world-series-trophies/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190821T120000
DTEND;TZID=America/Vancouver:20190821T130000
DTSTAMP:20190810T201259Z
CREATED:20190810T201259Z
LAST-MODIFIED:20190810T201259Z
UID:27307-1566388800-1566392400@scienceinboston.com
SUMMARY:HCBI Lunch and Learn Lecture Series
DESCRIPTION:Image analysis pipelines with KNIME and Ilastik – demonstrate building image analysis pipelines with KNIME\, using interactive image segmentation with Ilastik as an example. KNIME integrates all steps of image analysis into a manageable\, nodebased workflow and is compatible with ImageJ\, MATLAB\, etc. (Andrew Seeber)
URL:https://scienceinboston.com/event/hcbi-lunch-and-learn-lecture-series-2-2/
LOCATION:Biological Laboratories\, 16 Divinity Avenue Biological Labs Lecture Hall\, Room 1080\, Cambridge\, MA\, 02138\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190821T120000
DTEND;TZID=America/Vancouver:20190821T130000
DTSTAMP:20190810T201259Z
CREATED:20190810T201259Z
LAST-MODIFIED:20190810T201259Z
UID:6160-1566388800-1566392400@scienceinboston.com
SUMMARY:HCBI Lunch and Learn Lecture Series
DESCRIPTION:Image analysis pipelines with KNIME and Ilastik – demonstrate building image analysis pipelines with KNIME\, using interactive image segmentation with Ilastik as an example. KNIME integrates all steps of image analysis into a manageable\, nodebased workflow and is compatible with ImageJ\, MATLAB\, etc. (Andrew Seeber)
URL:https://scienceinboston.com/event/hcbi-lunch-and-learn-lecture-series-2/
LOCATION:Biological Laboratories\, 16 Divinity Avenue Biological Labs Lecture Hall\, Room 1080\, Cambridge\, MA\, 02138\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190815T170000
DTEND;TZID=America/Vancouver:20190815T190000
DTSTAMP:20190723T205025Z
CREATED:20190723T205025Z
LAST-MODIFIED:20190723T205025Z
UID:27306-1565888400-1565895600@scienceinboston.com
SUMMARY:MassBio Regional Mixer: Woburn
DESCRIPTION:Join MassBio for a Regional Mixer in Woburn! This growing area is home to many MassBio members\, and a key part of the local life sciences scene. MassBio members\, if you work or live in or around Woburn\, this is your chance to kick back with your coworkers and network. Never been to a MassBio event? This is a great event to start with! Regular attendee? Invite a coworker that’s never been. Appetizers and drinks will be served. \nMassBio members only. Registration required.
URL:https://scienceinboston.com/event/massbio-regional-mixer-woburn-2/
LOCATION:Strega Prime Woburn\, 100 Sylvan Rd\, Worburn\, MA\, 01801\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190815T170000
DTEND;TZID=America/Vancouver:20190815T190000
DTSTAMP:20190723T205025Z
CREATED:20190723T205025Z
LAST-MODIFIED:20190723T205025Z
UID:6002-1565888400-1565895600@scienceinboston.com
SUMMARY:MassBio Regional Mixer: Woburn
DESCRIPTION:Join MassBio for a Regional Mixer in Woburn! This growing area is home to many MassBio members\, and a key part of the local life sciences scene. MassBio members\, if you work or live in or around Woburn\, this is your chance to kick back with your coworkers and network. Never been to a MassBio event? This is a great event to start with! Regular attendee? Invite a coworker that’s never been. Appetizers and drinks will be served. \nMassBio members only. Registration required.
URL:https://scienceinboston.com/event/massbio-regional-mixer-woburn/
LOCATION:Strega Prime Woburn\, 100 Sylvan Rd\, Worburn\, MA\, 01801\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190814T120000
DTEND;TZID=America/New_York:20190814T123000
DTSTAMP:20190723T204148Z
CREATED:20190723T204148Z
LAST-MODIFIED:20190723T204148Z
UID:27304-1565784000-1565785800@scienceinboston.com
SUMMARY:Current and Future Trends in Oncology Care Delivery
DESCRIPTION:According to the American Cancer Society\, each year more than 1.7 million new cases of cancer are diagnosed. By 2020\, 18 million cancer survivors are expected in the United States alone. Emerging research and technologies are helping to rapidly change the pace of oncology discovery\, innovation and treatment. As a result\, high costs\, survivorship\, and a focus on patient-driven care are transforming how cancer care is delivered. \nIn this webinar\, Mara Bloom\, JD\, MS\, Executive Director of the Massachusetts General Hospital Cancer Center\, will present the cancer center as a case study for how we can use service line management to engage stakeholders and streamline healthcare delivery\, reduce costs\, improve patient experience and encourage continued innovation and growth. She will also discuss how a multidisciplinary care model leads to greater collaboration among physicians and researchers. Bloom also will highlight how the latest therapies\, technologies and care models\, including home hospital\, telemedicine and artificial intelligence will help shape the cancer center of the future.
URL:https://scienceinboston.com/event/current-and-future-trends-in-oncology-care-delivery-2/
LOCATION:Harvard Medical School Online Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190814T120000
DTEND;TZID=America/New_York:20190814T123000
DTSTAMP:20190723T204148Z
CREATED:20190723T204148Z
LAST-MODIFIED:20190723T204148Z
UID:5997-1565784000-1565785800@scienceinboston.com
SUMMARY:Current and Future Trends in Oncology Care Delivery
DESCRIPTION:According to the American Cancer Society\, each year more than 1.7 million new cases of cancer are diagnosed. By 2020\, 18 million cancer survivors are expected in the United States alone. Emerging research and technologies are helping to rapidly change the pace of oncology discovery\, innovation and treatment. As a result\, high costs\, survivorship\, and a focus on patient-driven care are transforming how cancer care is delivered. \nIn this webinar\, Mara Bloom\, JD\, MS\, Executive Director of the Massachusetts General Hospital Cancer Center\, will present the cancer center as a case study for how we can use service line management to engage stakeholders and streamline healthcare delivery\, reduce costs\, improve patient experience and encourage continued innovation and growth. She will also discuss how a multidisciplinary care model leads to greater collaboration among physicians and researchers. Bloom also will highlight how the latest therapies\, technologies and care models\, including home hospital\, telemedicine and artificial intelligence will help shape the cancer center of the future.
URL:https://scienceinboston.com/event/current-and-future-trends-in-oncology-care-delivery/
LOCATION:Harvard Medical School Online Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190813T113000
DTEND;TZID=America/Vancouver:20190813T130000
DTSTAMP:20190810T201602Z
CREATED:20190810T201602Z
LAST-MODIFIED:20190810T201602Z
UID:27308-1565695800-1565701200@scienceinboston.com
SUMMARY:Lunch & Learn: Structural Modeling of Textile-Reinforced\, Tissue-Engineered Heart Valves
DESCRIPTION:Heart valve defects or diseases can be very serious\, often requiring valve replacement.  Traditional synthetic heart valves can calcify or wear over time and the surgeries required can carry high risk and be very invasive.  To address these drawbacks\, researchers are developing tissue-engineered heart valves which can be inserted orthoscopically.  These tissue-engineered heart valves have the potential to make compatible and effective replacements\, but they are currently not strong enough to survive the high pressures found on the aortic side of the heart.  To strengthen the valves\, the tissue is grown around a textile reinforcement: too little reinforcement and the valve tears\, too much and it does not function correctly.  This presentation\, by UMass Lowell Professor Scott Stapleton of mechanical engineering\, will summarize efforts to computationally model the hierarchical heart valve structure\, with the intent of designing and optimizing textile reinforcement to strengthen the valve while maintaining its proper function.
URL:https://scienceinboston.com/event/lunch-learn-structural-modeling-of-textile-reinforced-tissue-engineered-heart-valves-2/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20190813T113000
DTEND;TZID=America/Vancouver:20190813T130000
DTSTAMP:20190810T201602Z
CREATED:20190810T201602Z
LAST-MODIFIED:20190810T201602Z
UID:6161-1565695800-1565701200@scienceinboston.com
SUMMARY:Lunch & Learn: Structural Modeling of Textile-Reinforced\, Tissue-Engineered Heart Valves
DESCRIPTION:Heart valve defects or diseases can be very serious\, often requiring valve replacement.  Traditional synthetic heart valves can calcify or wear over time and the surgeries required can carry high risk and be very invasive.  To address these drawbacks\, researchers are developing tissue-engineered heart valves which can be inserted orthoscopically.  These tissue-engineered heart valves have the potential to make compatible and effective replacements\, but they are currently not strong enough to survive the high pressures found on the aortic side of the heart.  To strengthen the valves\, the tissue is grown around a textile reinforcement: too little reinforcement and the valve tears\, too much and it does not function correctly.  This presentation\, by UMass Lowell Professor Scott Stapleton of mechanical engineering\, will summarize efforts to computationally model the hierarchical heart valve structure\, with the intent of designing and optimizing textile reinforcement to strengthen the valve while maintaining its proper function.
URL:https://scienceinboston.com/event/lunch-learn-structural-modeling-of-textile-reinforced-tissue-engineered-heart-valves/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190808T113000
DTEND;TZID=America/New_York:20190808T130000
DTSTAMP:20190723T203946Z
CREATED:20190723T203946Z
LAST-MODIFIED:20190723T203946Z
UID:5996-1565263800-1565269200@scienceinboston.com
SUMMARY:Lunch & Learn: Small Business Innovation Research Grant
DESCRIPTION:Do you have the next great tech idea? \nThe Small Business Innovation Research Program (SBIR) is a $2.4 billion federal grant program established to support R&D that has potential for commercialization. \nDan Lilly\, Small Business Innovation Research Advisor\,  will provide an overview of the SBIR program\, including information on the program’s purpose\, eligibility\, sources of funding\, and foundational knowledge of what is necessary to succeed. \nThis seminar is designed to help you determine if the program is right for you\, and to begin efforts to develop an SBIR proposal.
URL:https://scienceinboston.com/event/lunch-learn-small-business-innovation-research-grant/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190808T113000
DTEND;TZID=America/New_York:20190808T130000
DTSTAMP:20190723T203946Z
CREATED:20190723T203946Z
LAST-MODIFIED:20190723T203946Z
UID:27303-1565263800-1565269200@scienceinboston.com
SUMMARY:Lunch & Learn: Small Business Innovation Research Grant
DESCRIPTION:Do you have the next great tech idea? \nThe Small Business Innovation Research Program (SBIR) is a $2.4 billion federal grant program established to support R&D that has potential for commercialization. \nDan Lilly\, Small Business Innovation Research Advisor\,  will provide an overview of the SBIR program\, including information on the program’s purpose\, eligibility\, sources of funding\, and foundational knowledge of what is necessary to succeed. \nThis seminar is designed to help you determine if the program is right for you\, and to begin efforts to develop an SBIR proposal.
URL:https://scienceinboston.com/event/lunch-learn-small-business-innovation-research-grant-2/
LOCATION:M2D2\, 600 Suffolk Street\, 2nd Floor\, Suite 250\, Suffolk\, MA\, 01854\, United States
END:VEVENT
END:VCALENDAR